Bactrim 400 mg / 80 mg Noruega - noruego - Statens legemiddelverk

bactrim 400 mg / 80 mg

eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - tablett - 400 mg / 80 mg

Entocort 3 mg Noruega - noruego - Statens legemiddelverk

entocort 3 mg

tillotts pharma gmbh - budesonid - depotkapsel, hard - 3 mg

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Unión Europea - noruego - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrelhydroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antithrombotic agents - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Levetiracetam Aristo 100 mg/ ml Noruega - noruego - Statens legemiddelverk

levetiracetam aristo 100 mg/ ml

aristo pharma gmbh - levetiracetam - mikstur, oppløsning med druesmak - 100 mg/ ml

Trica 20 mg/ ml Noruega - noruego - Statens legemiddelverk

trica 20 mg/ ml

esteve pharmaceuticals gmbh - triamcinolonheksacetonid - injeksjonsvæske, suspensjon - 20 mg/ ml

Ursofalk 250 mg Noruega - noruego - Statens legemiddelverk

ursofalk 250 mg

dr. falk pharma gmbh - ursodeoksykolsyre - kapsel, hard - 250 mg

Anagrelide AOP 0.5 mg Noruega - noruego - Statens legemiddelverk

anagrelide aop 0.5 mg

aop orphan pharmaceuticals gmbh - anagrelidhydroklorid monohydrat - kapsel, hard - 0.5 mg

Dificlir Unión Europea - noruego - EMA (European Medicines Agency)

dificlir

tillotts pharma gmbh - fidaxomicin - clostridiuminfeksjoner - antidiarrheals, intestinal betennelsesdempende / antiinfective agents - dificlir filmdrasjerte tabletter er angitt for behandling av clostridioides difficile infeksjoner (cdi), også kjent som c. difficile-assosiert diaré (cdad) i voksne og paediatric pasienter med en kroppsvekt på minst 12. 5 kg. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler. dificlir granulat til mikstur er angitt for behandling av clostridioides difficile infeksjoner (cdi), også kjent som c. difficile-assosiert diaré (cdad) i voksne og paediatric pasienter fra fødsel til < 18 år. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Vantobra Unión Europea - noruego - EMA (European Medicines Agency)

vantobra

pari pharma gmbh - tobramycin - cystic fibrosis; respiratory tract infections - antibakterielle midler for systemisk bruk , aminoglycoside antibakterielle midler - vantobra er indisert for behandling av kronisk lunginfeksjon på grunn av pseudomonas aeruginosa hos pasienter i alderen 6 år og eldre med cystisk fibrose (cf). det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Niferex 100 mg Noruega - noruego - Statens legemiddelverk

niferex 100 mg

ucb pharma gmbh - jern(ii)glysinsulfat - enterokapsel, hard - 100 mg